Comparison of the DCE and DW MR parameters among control, erlotinib, and combined erlotinib and bevacizumab (BEV) groups in HCC827R.
收藏数据链接：
官方服务：
资源简介：
Comparison of the DCE and DW MR parameters among control, erlotinib, and combined erlotinib and bevacizumab (BEV) groups in HCC827R.
创建时间：
2017-11-10
